Infective Endocarditis Management

Diagnosis

• Transthoracic echocardiography (TTE) is the first-line imaging modality for diagnosing tricuspid valve vegetation, with transesophageal echocardiography (TEE) used if TTE is non-diagnostic or to assess for pulmonary vegetations and left-sided involvement, as recommended by the European Society of Cardiology 1
• Blood culture-negative infective endocarditis (BCNIE) occurs in up to 31% of all IE cases, significantly impacting clinical outcomes due to delayed diagnosis and treatment, with prior antibiotic administration being the most common cause of BCNIE, reducing bacterial recovery by 35-40% 2, 3
• Histopathological examination of resected valvular tissue or embolic fragments is the gold standard for diagnosis, and specialized serological testing for common BCNIE pathogens should be considered 2
• If antibiotics were given before cultures, consider withdrawing antibiotics and repeating blood cultures if the patient is stable 2

Treatment

• The European Society of Cardiology recommends a 2-week course of penicillinase-resistant penicillin (oxacillin or cloxacillin) without gentamicin for uncomplicated methicillin-susceptible Staphylococcus aureus (MSSA) infections in patients with tricuspid valve vegetation, with specific criteria including good response to treatment, absence of metastatic infection sites, absence of cardiac/extracardiac complications, and absence of associated prosthetic valve or left-sided infection 1
• Vancomycin is recommended for methicillin-resistant Staphylococcus aureus (MRSA) infections, with a dosage of 30 mg/kg/24h IV in 2 divided doses for 6 weeks, and adjusted to achieve a 1-hour serum concentration of 30-45 μg/ml and trough of 10-15 μg/ml 4
• Empiric antibiotic therapy should be initiated based on likely pathogens, with Vancomycin plus ceftriaxone pending culture results for native valve endocarditis, and Vancomycin, gentamicin, and rifampin for prosthetic valve endocarditis, as recommended by the European Society of Cardiology 1

• Specific treatment regimens are required for certain pathogens, including:

  | Pathogen | Proposed Treatment | Duration | |----------|----------------------|----------| | Brucella spp. | Doxycycline + cotrimoxazole + rifampin | ≥3-6 months | | C. burnetii (Q fever) | Doxycycline + hydroxychloroquine | >18 months | | Bartonella spp. | Doxycycline + gentamicin | Doxycycline for 4 weeks, gentamicin for 2 weeks | | Legionella spp. | Doxycycline + hydroxychloroquine | ≥18 months | | Mycoplasma spp. | Doxycycline + gentamicin | Variable | | T. whipplei | Doxycycline + hydroxychloroquine | ≥18 months | 1

Surgical Options

• Surgical options for infective endocarditis include valve repair (preferred when possible), valve replacement (bioprosthetic preferred in this population), and valvectomy (in extreme cases, but may lead to right heart failure) 1
• Cardiac surgery consultation is recommended for evaluation in cases of heart failure due to valvular dysfunction, uncontrolled infection despite appropriate antibiotics, large mobile vegetations (>10mm) with embolic risk, or perivalvular abscess or fistula formation, as recommended by the European Society of Cardiology 1
• Urgent surgical consultation should be considered for potential emergency valve surgery if signs of heart failure or cardiogenic shock are present, or if there is evidence of uncontrolled infection, as recommended by the European Society of Cardiology 1
• Prosthetic valve infection, regardless of fungal causes, is an indication for surgery, and the American Heart Association recommends early surgical intervention for S. aureus prosthetic valve endocarditis to maximize outcomes 3

Special Considerations

• Patients with HIV infection and CD4 count <200 cells/mL may require more aggressive management due to a worse prognosis 1
• Recurrence risk is high with continued drug use, emphasizing the importance of addiction treatment 1
• Patients should be monitored for antibiotic toxicity, especially if aminoglycosides are added, as recommended by the American College of Cardiology 3
• A complete dental evaluation should be performed to eliminate sources of infection, as suggested by the American Heart Association 3

Follow-up Care

• Daily clinical assessment, serial blood cultures until sterilization, regular echocardiographic follow-up, monitoring of renal function, and drug level monitoring for Gentamicin and Vancomycin, with target trough levels of <1 mg/L and 10-15 μg/mL, respectively, and peak levels of 10-12 mg/L and 30-45 μg/mL, respectively, are recommended for patients with infectious endocarditis 1
• Clinical evaluation at 1, 3, 6, and 12 months, echocardiography at completion of therapy, blood cultures if recurrent fever, and dental follow-up and emphasis on prophylaxis for future procedures are recommended for follow-up care 1, 3
• Outpatient treatment may be considered after the critical phase (first 2 weeks) for medically stable patients without heart failure, concerning echocardiographic findings, neurological symptoms, or renal insufficiency, with regular follow-up (nursing staff daily, treating physician 1-2 times/week) 1

Multidisciplinary Approach

• The European Society of Cardiology recommends a multidisciplinary team approach with prompt initiation of appropriate antibiotic therapy, consideration for surgical intervention in specific cases, and careful monitoring for complications in the management of infective endocarditis 1
• Early consultation with infectious disease specialists is strongly recommended, particularly for non-HACEK gram-negative endocarditis, and surgical intervention is indicated for prosthetic valve infections 1